Erica Jackson is a partner in the firm’s food, drugs, medical devices and cosmetics (FDA) and health care practice groups. Her solutions-oriented approach to strategic counseling is deeply informed by her background in health policy and public health and in-house, government, and intergovernmental organization experience. She has a passion for helping her clients advance innovative products and access to quality health services.
Ms. Jackson regularly advises life sciences, cosmetics, dietary supplement, and food companies in regulatory, enforcement, compliance, and transactional matters relating to the development, manufacturing, distribution and marketing of products regulated by the FDA. In addition, she advises clients on health care fraud and abuse risk mitigation strategies and matters involving the Centers for Disease Control and Prevention (CDC), Drug Enforcement Administration (DEA), the Federal Trade Commission (FTC), the Centers for Medicare and Medicaid Services (CMS), the U.S. Department of Agriculture (USDA), and similar state regulatory agencies.
Ms. Jackson’s areas of focus include advising clients on innovative technologies and products, including digital health and personalized medicine. She regularly counsels clients on promotion and labeling matters. She has also conducted internal investigations on healthcare fraud and abuse matters and promotional practices. In addition, she regularly advises clients on FDA and health care regulatory matters during acquisitions of life sciences and health care companies, and other transactional matters, including clinical trial, licensing, quality, material transfer, consulting, and related agreements.